Enjoy complimentary customisation on priority with our Enterprise License!
The cancer immunotherapy market size is estimated to grow by USD 45.5 billion at a CAGR of 8.1% between 2023 and 2028. The high prevalence of cancer worldwide is increasing the demand for effective treatment options, driving the growth of the market. Growing awareness among consumers regarding the benefits of cancer immunotherapy, which offers targeted and personalized treatment options with potentially fewer side effects, is also driving market growth. Additionally, the strong R&D pipeline of monoclonal antibodies, which are a key component of many cancer biologics and immunotherapy treatments, is fueling innovation in the field and expanding treatment options for patients. Overall, these factors are creating a favorable market environment for cancer immunotherapy and driving advancements in cancer treatment.
The research and development pipeline of monoclonal antibodies is dominated by cancer immunotherapy system indications. Among these, in view of increasing cancer prevalence and the high uptake of monoclonal antibodies as treatment options, oncology drugs appear to be a major therapeutic area for monoclonal antibodies. Both large and small players are investing in the development of monoclonal antibodies, but Novartis has the largest pipeline for monoclonal antibodies. However, a very small fraction of monoclonal antibodies in R&D programs have reached the clinical and marketing phases for anti-infection and neuropharmacological monoclonal antibodies. The adoption of novel therapeutics in cancer immunotherapy is being aided by R&D activities for new technology.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.